Page results
-
GP portal (now called EpicCare Link UCLH) allows GPs to access information about patients they have referred to UCLH.
-
Become a member of UCLH. We want to better reflect the diversity of the communities we serve and meet the needs of our local community, patients and staff.
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
POEMS syndrome is a rare condition caused by the body producing abnormal plasma cells (a type of blood cell which produces antibodies to fight off infections).
-
The Freedom of Information Act 2000 (FOIA) came into force on 1 January 2005 giving members of the public certain rights to ask public authorities for information relating to the public authority.
-
Individuals are able to access their own. In some cases certain third parties have the right to ask for copies of medical records.
-
Dr Maria Michelagnoli is a paediatric oncologist with a special interest in bone tumours, rhabdomyosarcoma, fibromatosis and bone presentations of LCH
-
Volunteers are a highly valued part of the team at UCLH. Volunteering is a great way of giving back, doing something different and get some experience. Roles tend to be for a minimum of half a day a week for 6 months. For most of our roles you don’t necessarily need have to have prior experience as the key things we are looking for are great people skills and an ability to give us a regular commitment.
-
Dr Roser Vega is a consultant gastroenterologist and interventional colonoscopist. She leads the University College Hospital interventional colonoscopy service, providing advanced diagnosis and endoscopic treatment for colonic polyps and early colon cancers. She also delivers specialist care to patients with complex inflammatory bowel disease.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
File results
-
FOI/2022/0551 - Procurement contact details
-
FOI/2022/0555 - Senior staff contact details
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0542 - Infection control audits from September 2020 to April 2021
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0559 - Proton Beam Therapy contract
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology